Implications of Telemedicine in Oncology during the COVID-19 Pandemic
- PMID: 32921719
- PMCID: PMC7716949
- DOI: 10.23750/abm.v91i3.9849
Implications of Telemedicine in Oncology during the COVID-19 Pandemic
Abstract
COVID-19 has had a catastrophic effect on healthcare systems compromising the treatment of cancer patients. It has an increased disease burden in the cancer population. As a result, tele-oncology services have become essential to reduce the risk of cancer patients being exposed to the deadly pathogen. Many governmental establishments have endorsed the use of tele-oncology during COVID-19 era. However, telemedicine in oncology still has certain drawbacks that can be improved upon. Nevertheless, tele-oncology has shown great promise to support cancer care not only during this pandemic but also become a part of normal care in the future.
Conflict of interest statement
Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article
References
-
- World Health Organisation. WHO Coronavirus Disease (COVID-19) Dashboard. Available: https://covid19.who.int . 7 June 2020.
-
- American Telemedicine Association. Telemedicine, Telehealth, and Health Information Technology [Internet]. Who.int. 2006 [cited 10 June 2020] Available from: https://www.who.int/goe/policies/countries/usa_support_tele.pdf?ua=1 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials